Cypress Capital Management LLC WY Sells 560 Shares of Colgate-Palmolive (NYSE:CL)

Cypress Capital Management LLC WY decreased its position in Colgate-Palmolive (NYSE:CL) by 35.9% during the fourth quarter, HoldingsChannel reports. The firm owned 1,000 shares of the company’s stock after selling 560 shares during the quarter. Cypress Capital Management LLC WY’s holdings in Colgate-Palmolive were worth $80,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently modified their holdings of the company. Patriot Financial Group Insurance Agency LLC grew its stake in shares of Colgate-Palmolive by 12.2% in the third quarter. Patriot Financial Group Insurance Agency LLC now owns 3,034 shares of the company’s stock worth $216,000 after acquiring an additional 329 shares during the last quarter. Harbor Capital Advisors Inc. boosted its stake in Colgate-Palmolive by 2.3% during the third quarter. Harbor Capital Advisors Inc. now owns 15,278 shares of the company’s stock worth $1,086,000 after buying an additional 342 shares in the last quarter. Toews Corp ADV acquired a new stake in Colgate-Palmolive during the third quarter worth $782,000. Kingswood Wealth Advisors LLC acquired a new stake in Colgate-Palmolive during the third quarter worth $880,000. Finally, Robeco Institutional Asset Management B.V. boosted its stake in Colgate-Palmolive by 2.6% during the third quarter. Robeco Institutional Asset Management B.V. now owns 1,468,376 shares of the company’s stock worth $104,416,000 after buying an additional 37,074 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Insiders Place Their Bets

In other Colgate-Palmolive news, insider Jennifer Daniels sold 3,538 shares of the company’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.67, for a total transaction of $299,562.46. Following the completion of the transaction, the insider now owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, EVP Gregory Malcolm sold 8,930 shares of the firm’s stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $85.35, for a total transaction of $762,175.50. Following the completion of the sale, the executive vice president now owns 8,043 shares of the company’s stock, valued at approximately $686,470.05. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jennifer Daniels sold 3,538 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.67, for a total value of $299,562.46. Following the sale, the insider now directly owns 59,698 shares of the company’s stock, valued at approximately $5,054,629.66. The disclosure for this sale can be found here. Insiders sold a total of 232,371 shares of company stock valued at $19,505,099 in the last quarter. 0.37% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on CL shares. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. Wells Fargo & Company lifted their price target on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research note on Monday. Bank of America boosted their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research note on Monday. UBS Group boosted their target price on shares of Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Finally, Royal Bank of Canada boosted their target price on shares of Colgate-Palmolive from $88.00 to $95.00 and gave the company a “sector perform” rating in a research note on Monday. Three research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Based on data from MarketBeat, Colgate-Palmolive has a consensus rating of “Moderate Buy” and a consensus target price of $91.38.

Colgate-Palmolive Trading Down 0.8 %

Shares of CL stock traded down $0.69 on Monday, reaching $90.32. The company had a trading volume of 2,836,906 shares, compared to its average volume of 4,585,428. The company has a current ratio of 0.42, a quick ratio of 0.28 and a debt-to-equity ratio of 8.59. The stock has a market cap of $74.24 billion, a PE ratio of 28.55, a PEG ratio of 3.42 and a beta of 0.42. The company has a 50-day moving average of $87.66 and a 200-day moving average of $81.63. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $92.25.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The business had revenue of $5.07 billion during the quarter, compared to analyst estimates of $4.96 billion. During the same period in the previous year, the firm earned $0.73 EPS. Colgate-Palmolive’s quarterly revenue was up 6.2% compared to the same quarter last year. On average, equities analysts forecast that Colgate-Palmolive will post 3.5 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be given a $0.50 dividend. The ex-dividend date is Friday, April 19th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a dividend yield of 2.21%. Colgate-Palmolive’s payout ratio is currently 63.29%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.